Your session is about to expire
← Back to Search
Group Education for Type 1 Diabetes (GET-IT-T1D Trial)
N/A
Waitlist Available
Led By Meranda Nakhla, MD, MSc
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adolescents with a diagnosis of Type 1 Diabetes
16 to 17 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0,12, 24 months
Awards & highlights
GET-IT-T1D Trial Summary
This trial is examining whether group education visits integrated into pediatric care, compared with usual care, has an effect on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures after the transfer to adult care for emerging adults with type 1 diabetes (T1D).
Who is the study for?
This trial is for adolescents aged 16-17 with Type 1 Diabetes, fluent in English or French, and receiving care at specific clinics in Montreal. It's not for those with severe neurocognitive disabilities or conditions like hemolytic anemia that affect blood test accuracy.Check my eligibility
What is being tested?
The study tests if group education visits can help manage Type 1 Diabetes better than usual care alone. Participants will be randomly assigned to either the new approach or standard treatment and tracked for changes in their HbA1c levels and psychosocial outcomes over two years.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medications, there are no direct side effects from drugs. However, participants may experience stress or anxiety related to group settings or discussions about their condition.
GET-IT-T1D Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a teenager diagnosed with Type 1 Diabetes.
Select...
I am 16 or 17 years old.
GET-IT-T1D Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0,12, 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0,12, 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hemaglobin A1c (HbA1c)
Secondary outcome measures
Cost effectiveness (HbA1c)
Cost effectiveness (QOL)
Cost effectiveness (self-efficacy)
+12 moreGET-IT-T1D Trial Design
2Treatment groups
Experimental Treatment
Group I: ControlExperimental Treatment1 Intervention
Usual diabetes care, every 3 months for 12 months, which consists of visits with their diabetes care physician. In addition, as per usual diabetes care, an individual education session and written information will be provided before formal transfer.
Group II: ActiveExperimental Treatment1 Intervention
≥3 group education sessions (60 minutes per session) in addition to usual diabetes care, every 3 months for 12 months. Each group session (3-8 patients per group) will be facilitated by a diabetes nurse educator and/or dietitian. The group session content will be guided by the needs of the group participants. The group discussion will end with participants setting goals for their next appointment.
Find a Location
Who is running the clinical trial?
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,340 Previous Clinical Trials
26,452,486 Total Patients Enrolled
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
442 Previous Clinical Trials
158,962 Total Patients Enrolled
St. Justine's HospitalOTHER
196 Previous Clinical Trials
78,817 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are being treated for diabetes at Montreal Children's Hospital (MCH) or Centre Hospitalier Universitaire Sainte Justine (CHUSJ).I have a condition like hemolytic anemia that affects my red blood cell lifespan.I do not have severe mental disabilities that would stop me from joining group learning sessions.I am a teenager diagnosed with Type 1 Diabetes.I am 16 or 17 years old.I am fluent in English or French.
Research Study Groups:
This trial has the following groups:- Group 1: Active
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the eligibility criteria for participating in this experiment?
"This clinical trial necessitates that potential patients possess both diabetes and an autoimmune disorder, in addition to being aged 16-17. Presently, the study is seeking approximately 212 participants."
Answered by AI
Are there any current vacancies for participants in this experiment?
"Currently, the clinical trial listed on clinicialtrials.gov is no longer accepting patients for enrollment; it was initially posted in November 2019 and most recently updated in November 2021. Though this specific study has ended its recruitment period, 1264 other studies are actively seeking volunteers."
Answered by AI
Are participants below the age of thirty eligible to join this trial?
"According to the requirements for participation, only those aged 16 and 17 are eligible. Additionally, there are 219 clinical trials actively recruiting minors while 925 studies target elderly participants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger